What Researchers Did
Researchers conducted a meta-analysis to evaluate if hyperbaric oxygen therapy helps reduce the high mortality rate in patients with Fournier's gangrene.
What They Found
This meta-analysis of 14 studies found that hyperbaric oxygen therapy was associated with lower mortality in patients with Fournier's gangrene. The analysis included 793 patients, with 356 receiving hyperbaric oxygen therapy and 437 receiving conventional therapy alone. The mortality rate in the hyperbaric oxygen therapy group was 9.55%, significantly lower than the 27.45% mortality rate observed in the conventional therapy group.
Canadian Relevance
Fournier's gangrene is not a Health Canada-recognized indication for hyperbaric oxygen therapy. No direct Canadian connection identified.
Study Limitations
The study highlights the need for more rigorous randomized controlled trials to determine the optimal hyperbaric oxygen therapy dosage and identify specific patient groups who would benefit most.